Differential effects of IL-1/β and ibuprofen after endotoxic challenge in mice

Journal of Surgical Research

Volumn 67, Issue 2, 1997, Pages 199-204

  Mansilla Rosello A ^a   Ferron Orihuela J A ^a   Ruiz Cabello, F ^a   Garrote Lara, D ^a   Fernandez Mondejar E ^a   Delgado Carrasco, M L ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN; INTERLEUKIN 1BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DRUG EFFECT; ENDOTOXIN DETECTION; ESCHERICHIA COLI; IMMUNE RESPONSE; INFLAMMATORY CELL; MACROPHAGE ACTIVATION; MEDIATOR RELEASE; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK; SURVIVAL;

EID: 0031080339     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1996.4982     Document Type: Article

References (29)

1. 1. Goris, R. J. A. Mediators of multiple organ failure. Intensive Care Med. 16: 192, 1990.
2. 2. Freudenberg, M. A., Ness, T., Kumazawa, Y., and Galanos, C. The role of cytokines in endotoxic shock and in endotoxin hypersensitivity. Immun. Infekt. 21: 40, 1993.
3. 3. Offenstadt, G., Guidet, B., and Staikowsky, F. Cytokines and severe infections. Pathol. Biol. Paris 41: 820, 1993.
4. 4. Smith, S. R., Calzatta, A., Bankowski, J., Kenworthy-Bott, L., and Terminelli, C. Lipopolysaccharide-induced cytokine production and mortality in mice treated with Corynebacterium parvum. J. Leukocyte Biol. 54: 23, 1993.
5. 5. Miller-Graziano, C. L., Fink, M., Wu, J. Y., Szabo, G., and Kodys, K. Mechanisms of altered monocyte prostaglandin E2 production in severely injured patients. Arch. Surg. 123: 293, 1988.
6. 6. Vogels, M. T. E., Hermsen, C. C., Huys, H. L. P. G., Eling, W. M. C., and van der Meer, J. W. M. Roles of tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, platelet-activating factor, and arachidonic acid metabolites in interleukin-1-induced resistance to infection in neutropenic mice. Infect. Immun. 62: 2065, 1994.
7. 7. Pinsky, M. R. Cardiovascular response in canine endotoxic shock: Effect of ibuprofen pretreatment. Circ. Shock. 37: 323, 1992.
8. 8. Ozaki, Y., Ohashi, T., Minami, A., and Nakamura, S. Enhanced resistance of mice to bacterial infection induced by recombinant human interleukin-1 alpha. Infect. Immun. 55: 187, 1987.
9. 9. Van der Mer, J. W. M., Barza, M., Wolff, S. M., and Dinarello, C. A. A low dose of recombinant interleukin-1 protects granulocytopenic mice from lethal gram-negative infection. Immunology 85: 1620, 1988.
10. 10. Heumann, D., and Baumgartner, J. D. Cytokines et les infections bacteriennes et parasitaires. In J. M. Cavaillon (Ed.), Les Cytokines. Paris: Masson, 1993. Pp. 341-358.
11. 11. León, P., Redmond, H. P., Shou, J., and Daly, J. M. Interleukin 1 and its relationship to endotoxin tolerance. Arch. Surg. 127: 146, 1992.
12. 12. Fong, Y., Tracey, K. J., and Moldawer, L. L. Antibodies to cachectin/tumor necrosis factor reduce interleukin-1 beta and interleukin-6 appearance during lethal bacteriemia. J. Exp. Med. 170: 1627, 1989.
13. 2 receptors in peripheral blood mononuclear cells. J. Biol. Chem. 269: 9952, 1994.
14. 14. Lorre, K., Kasran, A., Van-Vaeck, F., de Boer, M., and Ceuppens, J. L. Interleukin-1 and B7/CD28 interaction regulate interleukin-6 production by human T cells. Clin. Immunol. Immunopathol. 70: 81, 1994.
15. 15. Fletcher, J. R., Collins, J. N., Graves, E. D., Luterman, A., Williams, M. D., Izenberg, S. D., and Rodning, C. B. Tumor necrosis factor-induced mortality is reversed with cyclooxygenase inhibition. Ann. Surg. 217: 668, 1993.
16. 16. Tracey, K. J., and Cerami, A. Metabolic responses to cachectin/ TNF: A brief review. Ann. N. Y. Acad. Sci. 587: 325, 1990.
17. 17. Ng, S. B., Tan, Y. H., and Guy, G. R. Differential induction of the interleukin-6 gene by tumor necrosis factor and interleukin-1. J. Biol. Chem. 269: 19021, 1994.
18. 18. Coran, A. G., Drongowski, R. A., Paik, J. J., and Remick, D. G. Ibuprofen intervention in canine septic shock: Reduction of pathophysiology without decreased cytokines. J. Surg. Res. 53: 272, 1992.
19. 19. Morley, J. Role of prostaglandins secreted by macrophages in the inflammatory process. Lymphokines 4: 377, 1981.
20. 20. Sironi, M., Gadina, M., Kankova, M., Riganti, F., Mantovani, A., Zandalasini, M., and Ghezzi, P. Differential sensitivity of in vivo tumor necrosis factor and interleukin-6 production to modulation by anti-inflammatory drugs in mice. Int. J. Immunopharmacol. 14: 1045, 1992.
21. 2 regulates macrophage-derived tumor necrosis factor gene expression. J. Biol. Chem. 263: 5380, 1988.
22. 22. Spinas, G. A., Bloesch, D., Keller, U., Zimmerli, W., and Cammisuli, S. Pretreatment with ibuprofen augments circulating tumor necrosis factor alpha, interleukin-6, and elastase during acute endotoxemia. J. Infect. Dis. 163: 89, 1991.
23. 23. Ertel, W., Morrison, M., Ayala, A., Perrin, M. M., and Chaudry, I. H. Blockade of prostaglandin production increases cachectin synthesis and prevents depression of macrophage function after hemorrhagic shock. Ann. Surg. 213: 265, 1991.
24. 24. Kupper, T. S., Green, D. R., Durum, S. K., and Baker, C. C. Defective antigen presentation to a cloned T helper cell by macrophages from burned mice can be restored with interleukin-1. Surgery 98: 199, 1985.
25. 25. Czuprynski, C. J., Brown, J. F., Young, K. M., Cooley, A. J., and Kurtz, R. S. Effects of murine recombinant interleukin-1 alpha on the host response to bacterial infection. J. Immunol. 140: 962, 1988.
26. 26. Shi, J., Goodband, R. D., Chengappa, M. M., Nelssen, J. L., Tokach, M. D., McVey, D. S., and Blecha, F. Influence of interleukin-1 on neutrophil function and resistance to Streptococcus suis in neonatal pigs. J. Leukocyte Biol. 56: 88, 1994.
27. 27. O'Riordain, M. G., Collins, K. H., Pilz, M., Saporoschetz, I. B., Mannick, J. A., and Rodrick, M. L. Modulation of macrophage hyperactivity improves survival in a burn-sepsis model. Arch. Surg. 127: 152, 1992.
28. 28. Yamanaka, S., Iwao, H., Yukimura, T., Kim, S., and Miura, K. Effect of the platelet-activating factor antagonist, TCV-309, and the cyclo-oxygenase inhibitor, ibuprofen, on the haemodynamic changes in canine experimental endotoxic shock. Br. J. Pharmacol. 110: 1501, 1993.
29. 29. Ochalski, S. J., Hartman, D. A., Belfast, M. T., Walter, T. L., Glaser, K. B., and Carlson, R. P. Inhibition of endotoxin-induced hypothermia and serum TNF-alpha levels in CD-1 mice by various pharmacological agents. Agents Actions 39: 52, 1993.